The adoption of digital pathology is a multifaceted project involving many stakeholders across the pathology department. The impact on the laboratory is not isolated to simply installing a scanner but rather affects the whole workflow to generate optimized Digital Ready Slides.
Standardization of histological slide preparation requires focusing on optimizing individual workflow steps and a holistic overview of the complete process from sample acquisition right through to diagnosis.
Knowing this in advance and taking appropriate steps to effectively support change management can promote engagement and pave a path to success.
Register for this webinar to gain insight into the laboratory considerations for the adoption of digital pathology, the key attributes of digital ready slides and the impact of tissue preparation steps on scan quality. Attendees will be introduced to the appropriate steps to support change management to help promote engagement and a path to success.
Olga Colgan, PhD, Strategic Marketing Director — Digital Solutions, Leica Biosystems
Dr. Olga Colgan has extensive experience in the digital pathology sector and is focused on how this technology can be leveraged to provide real benefits in both the healthcare and research domains. Prior to working with Leica Biosystems, she came from a research background with a BSc in biotechnology and a PhD in vascular biology from Dublin City University, Ireland.
Who Should Attend?
This webinar will appeal to scientists and cancer researchers interested in advancing translational science, in particular digital pathology, from pharmaceutical and biotech companies and universities.
- Research Scientist/Associate
- Principal Investigator/Scientist, Senior Scientist
- Pathologist, Toxicologic Pathologist
- Directors of R&D or Digital Imaging
- Lab Manager
- Research and Development Coordinator
- Managers in Pharmaceutical and Biotechnology Companies
What You Will Learn
After the webinar, attendees will be able to:
- Define the key attributes of Digital Ready Slides
- Demonstrate the impact of tissue preparation steps on scan quality
- Provide practical guidance to creating Digital Ready Slides and additional considerations at each laboratory step
Leica Biosystems (LeicaBiosystems.com) is a cancer diagnostics company and a global leader in workflow solutions. Only Leica Biosystems offers the most comprehensive portfolio that spans the entire workflow from biopsy to diagnosis. With unique expertise, we are dedicated to driving innovations that connect people across radiology, pathology, surgery and oncology. Our experts are committed to delivering Improved Quality, Integrated Solutions, and Optimized Efficiencies leading to breakthrough advances in diagnostic confidence. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Leica Biosystems is headquartered in Germany and operates in over 100 countries.